Cargando…

Prevalence and correlates of experiencing drug-related discrimination among people who use drugs presenting at emergency department at high risk of opioid overdose

OBJECTIVES: Our objective is to determine if specific sociodemographic characteristics were associated with perceived drug-related discrimination among people who use drugs (PWUD) presenting for care in the emergency department (ED). METHODS: We conducted a secondary analysis of data from the Naviga...

Descripción completa

Detalles Bibliográficos
Autores principales: Nolen, Shayla, Wilson, Taneisha, Jacka, Brendan P., Li, Yu, Beaudoin, Francesca L., Marshall, Brandon D.L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213175/
https://www.ncbi.nlm.nih.gov/pubmed/37249941
http://dx.doi.org/10.1016/j.abrep.2023.100496
_version_ 1785047559793803264
author Nolen, Shayla
Wilson, Taneisha
Jacka, Brendan P.
Li, Yu
Beaudoin, Francesca L.
Marshall, Brandon D.L.
author_facet Nolen, Shayla
Wilson, Taneisha
Jacka, Brendan P.
Li, Yu
Beaudoin, Francesca L.
Marshall, Brandon D.L.
author_sort Nolen, Shayla
collection PubMed
description OBJECTIVES: Our objective is to determine if specific sociodemographic characteristics were associated with perceived drug-related discrimination among people who use drugs (PWUD) presenting for care in the emergency department (ED). METHODS: We conducted a secondary analysis of data from the Navigator trial, a randomized control trial of two behavioral interventions in the ED for people at risk of an opioid overdose. Participants included adult patients presenting to two Rhode Island EDs. Eligible participants included those high risk for an opioid overdose, resided or received most of their healthcare in Rhode Island, and were able to provide consent. The primary outcome of this analysis was self-reported feelings of drug-related discrimination by the medical community. The independent variables of interest included race/ethnicity, gender identity, and sexual orientation. Log-binomial multivariable regression models were constructed with all three independent variables of interest and a selection of sociodemographic covariates. RESULTS: Of 620 eligible participants, 251 (40.5%) reported ever experiencing drug-related discrimination in their lifetime. In the adjusted model, participants who identified as women and participants who identified as LGBQIA+ were more likely to report experiencing drug-related discrimination from the medical community in EDs. Racial/ethnic minority groups were less likely than White (non-Hispanic) participants to report drug-related discrimination. DISCUSSION: In this study population, White participants reported more drug-related discrimination than their minority counterparts, although female and LGBQIA+ patients reported more discrimination. Future studies should further assess the significance of these intersecting identities on self-reported discrimination. This knowledge could improve ED-based interventions, policies, and services for PWUD.
format Online
Article
Text
id pubmed-10213175
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-102131752023-05-27 Prevalence and correlates of experiencing drug-related discrimination among people who use drugs presenting at emergency department at high risk of opioid overdose Nolen, Shayla Wilson, Taneisha Jacka, Brendan P. Li, Yu Beaudoin, Francesca L. Marshall, Brandon D.L. Addict Behav Rep Short Communication OBJECTIVES: Our objective is to determine if specific sociodemographic characteristics were associated with perceived drug-related discrimination among people who use drugs (PWUD) presenting for care in the emergency department (ED). METHODS: We conducted a secondary analysis of data from the Navigator trial, a randomized control trial of two behavioral interventions in the ED for people at risk of an opioid overdose. Participants included adult patients presenting to two Rhode Island EDs. Eligible participants included those high risk for an opioid overdose, resided or received most of their healthcare in Rhode Island, and were able to provide consent. The primary outcome of this analysis was self-reported feelings of drug-related discrimination by the medical community. The independent variables of interest included race/ethnicity, gender identity, and sexual orientation. Log-binomial multivariable regression models were constructed with all three independent variables of interest and a selection of sociodemographic covariates. RESULTS: Of 620 eligible participants, 251 (40.5%) reported ever experiencing drug-related discrimination in their lifetime. In the adjusted model, participants who identified as women and participants who identified as LGBQIA+ were more likely to report experiencing drug-related discrimination from the medical community in EDs. Racial/ethnic minority groups were less likely than White (non-Hispanic) participants to report drug-related discrimination. DISCUSSION: In this study population, White participants reported more drug-related discrimination than their minority counterparts, although female and LGBQIA+ patients reported more discrimination. Future studies should further assess the significance of these intersecting identities on self-reported discrimination. This knowledge could improve ED-based interventions, policies, and services for PWUD. Elsevier 2023-05-18 /pmc/articles/PMC10213175/ /pubmed/37249941 http://dx.doi.org/10.1016/j.abrep.2023.100496 Text en © 2023 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Short Communication
Nolen, Shayla
Wilson, Taneisha
Jacka, Brendan P.
Li, Yu
Beaudoin, Francesca L.
Marshall, Brandon D.L.
Prevalence and correlates of experiencing drug-related discrimination among people who use drugs presenting at emergency department at high risk of opioid overdose
title Prevalence and correlates of experiencing drug-related discrimination among people who use drugs presenting at emergency department at high risk of opioid overdose
title_full Prevalence and correlates of experiencing drug-related discrimination among people who use drugs presenting at emergency department at high risk of opioid overdose
title_fullStr Prevalence and correlates of experiencing drug-related discrimination among people who use drugs presenting at emergency department at high risk of opioid overdose
title_full_unstemmed Prevalence and correlates of experiencing drug-related discrimination among people who use drugs presenting at emergency department at high risk of opioid overdose
title_short Prevalence and correlates of experiencing drug-related discrimination among people who use drugs presenting at emergency department at high risk of opioid overdose
title_sort prevalence and correlates of experiencing drug-related discrimination among people who use drugs presenting at emergency department at high risk of opioid overdose
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213175/
https://www.ncbi.nlm.nih.gov/pubmed/37249941
http://dx.doi.org/10.1016/j.abrep.2023.100496
work_keys_str_mv AT nolenshayla prevalenceandcorrelatesofexperiencingdrugrelateddiscriminationamongpeoplewhousedrugspresentingatemergencydepartmentathighriskofopioidoverdose
AT wilsontaneisha prevalenceandcorrelatesofexperiencingdrugrelateddiscriminationamongpeoplewhousedrugspresentingatemergencydepartmentathighriskofopioidoverdose
AT jackabrendanp prevalenceandcorrelatesofexperiencingdrugrelateddiscriminationamongpeoplewhousedrugspresentingatemergencydepartmentathighriskofopioidoverdose
AT liyu prevalenceandcorrelatesofexperiencingdrugrelateddiscriminationamongpeoplewhousedrugspresentingatemergencydepartmentathighriskofopioidoverdose
AT beaudoinfrancescal prevalenceandcorrelatesofexperiencingdrugrelateddiscriminationamongpeoplewhousedrugspresentingatemergencydepartmentathighriskofopioidoverdose
AT marshallbrandondl prevalenceandcorrelatesofexperiencingdrugrelateddiscriminationamongpeoplewhousedrugspresentingatemergencydepartmentathighriskofopioidoverdose